MINI FUTURE LONG - IPSEN | Market Closed - Euronext Paris 10:00:01 10/05/2024 pm IST | ||
| 2.545 EUR | +0.39% |
|
| Current month | +12.36% | ||
| 1 month | +26.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 2.545 | +0.39% | 41 |
| 09/24/09 | 2.535 | +6.29% | 51 |
| 08/24/08 | 2.385 | +3.02% | 48 |
| 07/24/07 | 2.315 | +1.31% | 38 |
| 06/24/06 | 2.285 | +0.44% | 27 |
Real-time Euronext Paris
Last update May 10, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| LN7BB | |
| ISIN | FRBNPP02F1O3 |
| Date issued | 25/03/2021 |
| Strike | 69.83 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.31 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.255 € |
|---|---|
| Lowest since issue | 0.345 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
119.9
EUR
Average target price
125.5
EUR
Spread / Average Target
+4.69%
- Stock Market
- Certificates
- LN7BB Certificat
